Jieun Uhm

Jieun Uhm

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Journal: Expert review of anticancer therapy

Published: September 07, 2026

Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Annals of hematology

Published: December 22, 2025

Outcomes of Haploidentical Stem Cell Transplantation in Upfront and Salvage Settings for Adult Patients with Severe Aplastic Anemia.

Outcomes of Haploidentical Stem Cell Transplantation in Upfront and Salvage Settings for Adult Patients with Severe Aplastic Anemia.

Journal: Transplantation and cellular therapy

Published: June 21, 2025

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study.

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study.

Journal: Haematologica

Published: March 28, 2024

Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation.

Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation.

Journal: Blood research

Published: March 23, 2023

Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey.

Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey.

Journal: Blood research

Published: October 13, 2020

Recent advances in chronic lymphocytic leukemia therapy.

Recent advances in chronic lymphocytic leukemia therapy.

Journal: Blood research

Published: December 02, 2019

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma.

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma.

Journal: International journal of molecular sciences

Published: February 22, 2019

Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.

Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.

Journal: International journal of oncology

Published: June 02, 2017

Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.

Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.

Journal: European journal of haematology

Published: April 19, 2017

A multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine.

A multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine.

Journal: Oncotarget

Published: February 10, 2017

Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD.

Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD.

Journal: Annals of hematology

Published: September 22, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026